Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model

被引:20
|
作者
Zhao, Yunge [1 ]
Gillen, Jacob R. [1 ]
Harris, David A. [1 ]
Kron, Irving L. [1 ]
Murphy, Michael P. [2 ]
Lau, Christine L. [1 ]
机构
[1] Univ Virginia Hlth Syst, Div Thorac & Cardiovasc Surg, Dept Surg, Charlottesville, VA USA
[2] Indiana Univ Sch Med, Vasc & Cardiac Ctr Adult Stem Cell Therapy, Indianapolis, IN 46202 USA
来源
关键词
REGULATORY T-CELLS; ISCHEMIA-REPERFUSION INJURY; ACUTE LUNG INJURY; BONE-MARROW; PROGENITOR CELLS; TRANSPLANTATION; REPAIR; PREVENTION; DISEASE; MICE;
D O I
10.1016/j.jtcvs.2013.09.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Bone marrow-derived mesenchymal stem cells (MSCs) have shown therapeutic potential in acute lung injury. Recently, placenta-derived human mesenchymal stem cells (PMSCs) have shown similarities with bone marrow-derived MSCs in terms of regenerative capabilities and immunogenicity. This study investigates the hypothesis that treatment with PMSCs reduces the development of bronchiolitis obliterans in a murine heterotopic tracheal transplant model. Methods: A murine heterotopic tracheal transplant model was used to study the continuum from acute to chronic rejection. In the treatment groups, PMSCs or PMSC-conditioned medium (PMSCCM) were injected either locally or intratracheally into the allograft. Phosphate-buffered saline (PBS) or blank medium was injected in the control groups. Tracheal luminal obliteration was assessed on sections stained with hematoxylin and eosin. Infiltration of inflammatory and immune cells and epithelial progenitor cells was assessed using immunohistochemistry and densitometric analysis. Results: Compared with injection of PBS, local injection of PMSCs significantly reduced luminal obliteration at 28 days after transplantation (P.015). Intratracheal injection of PMSCs showed similar results to local injection of PMSCs compared with injection of PBS and blank medium (P.022). Tracheas treated with PMSC/PMSCCM showed protection against the loss of epithelium on day 14, with an increase in P63+CK14+ epithelial progenitor cells and Foxp3+ regulatory T cells. In addition, injection of PMSCs and PMSCCM significantly reduced the number of neutrophils and CD3+ T cells on day 14. Conclusions: This study demonstrates that treatment with PMSCs is protective against the development of bronchiolitis obliterans in an heterotopic tracheal transplant model. These results indicate that PMSCs could provide a novel therapeutic option to reduce chronic rejection after lung transplant.
引用
收藏
页码:1668 / +
页数:15
相关论文
共 50 条
  • [41] Treatment of traumatic brain injury in adult rats with intravenous administration of human placenta-derived mesenchymal stem cells
    Lin, Cheng-Hsien
    Hsuan, Yogi Chang-Yo
    Su, Wenlynn B.
    Chen, Yu-Chien
    Chang, Ching-Ping
    Lin, Mao-Tsun
    BRAIN INJURY, 2016, 30 (5-6) : 642 - 642
  • [42] Comparison of bone marrow-derived mesenchymal stem cells and placenta-derived stem cells as an in vitro screening system for hepatotoxicty
    Lee, Hyun-Jung
    Jung, Jieun
    Na, Kyu-Hwan
    Hwang, Seong-Gyu
    Kim, Gi Jin
    MOLECULAR & CELLULAR TOXICOLOGY, 2009, 5 (03) : 56 - 56
  • [43] Cartilage repair by various concentrations of placenta-derived mesenchymal stem cells and hyaluronic acid hydrogels in a rabbit model
    Kim, J.
    Ha, C.
    Park, Y.
    Han, W.
    CYTOTHERAPY, 2020, 22 (05) : S179 - S179
  • [44] In vitro Screening System for Hepatotoxicity: Comparison of Bone-Marrow-Derived Mesenchymal Stem Cells and Placenta-Derived Stem Cells
    Lee, Hyun-Jung
    Cha, Kyeung Eun
    Hwang, Seong-Gyu
    Kim, Jin Kyeoung
    Kim, Gi Jin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (01) : 49 - 58
  • [45] CARTILAGE REPAIR BY VARIOUS CONCENTRATIONS OF PLACENTA-DERIVED MESENCHYMAL STEM CELLS AND HYALURONIC ACID HYDROGELS IN A RABBIT MODEL
    Ha, C.
    Rhim, J.
    Kim, J.
    Park, Y.
    Han, W.
    Choi, S.
    Lee, K.
    Park, H.
    CYTOTHERAPY, 2017, 19 (05) : S139 - S139
  • [46] Placenta-Derived Mesenchymal Stem Cells Restore the Ovary Function in an Ovariectomized Rat Model via an Antioxidant Effect
    Seok, Jin
    Park, Hyeri
    Choi, Jong Ho
    Lim, Ja-Yun
    Kim, Kyung Gon
    Kim, Gi Jin
    ANTIOXIDANTS, 2020, 9 (07) : 1 - 16
  • [47] CARTILAGE REPAIR BY VARIOUS CONCENTRATIONS OF PLACENTA-DERIVED MESENCHYMAL STEM CELLS AND HYALURONIC ACID HYDROGELS IN A RABBIT MODEL
    Rhim, J.
    Ha, C. -W.
    Park, Y. -B.
    Kim, J. -A.
    Han, W. -J.
    Choi, S.
    Lee, K.
    Park, H.
    Park, H. -J.
    OSTEOARTHRITIS AND CARTILAGE, 2017, 25 : S160 - S160
  • [48] Effect of chondrocyte-derived early extracellular matrix on chondrogenesis of placenta-derived mesenchymal stem cells
    Park, Yong-Beom
    Seo, Sinji
    Kim, Jin-A
    Heo, Jin-Chul
    Lim, Young-Cheol
    Ha, Chul-Won
    BIOMEDICAL MATERIALS, 2015, 10 (03)
  • [49] Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model
    Chen, Qiaoling
    Cheng, Ping
    Song, Na
    Yin, Tao
    He, Hong
    Yang, Li
    Chen, Xiancheng
    Wei, Yuquan
    ONCOLOGY LETTERS, 2012, 4 (03) : 413 - 418
  • [50] Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells
    Kim, Mi Jeong
    Shin, Kyung Seon
    Jeon, Jin Hee
    Lee, Dong Ryul
    Shim, Sung Han
    Kim, Jin Kyeoung
    Cha, Dong-Hyun
    Yoon, Tae Ki
    Kim, Gi Jin
    CELL AND TISSUE RESEARCH, 2011, 346 (01) : 53 - 64